🔴 MDxHealth is trading 10.15% down amid AI-spending concerns and rising oil prices

MDxHealth is trading at $0.19, down 10.15%, amid broader market pressure.

• Supplied price context shows consecutive gains before the October 22 decline; no fresh company-specific catalyst was identified for that date.
• Broader markets faced pressure from AI-spending concerns and rising oil prices tied to Strait of Hormuz tensions.
• On October 15, MDxHealth announced preliminary Q3 revenue of $22.7 million and suspended full-year revenue guidance; this is not a confirmed cause of the current move.